i had/ have similar concerns
Have you had a look at the profiles of other well used IV ABs?
I did some research in MIMs as to plasma half lives, excretion times etc of vancomycin, merepenum, cefazolin, ceftriaxone as these are commonly used ABs in my role and the results were not horrible in comparison
still monitoring the situation but not as alarmed as i was at first
Ann: MCRI Pilot Study- Positive Efficacy Data for Lung Infections, page-15
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.005(1.69%) |
Mkt cap ! $83.62M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 28.5¢ | $37.25K | 127.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 161128 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 9666 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |